Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

FORLANO, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.070
NA - Nord America 802
SA - Sud America 722
EU - Europa 206
AF - Africa 103
Totale 2.903
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 752
BR - Brasile 558
VN - Vietnam 325
SG - Singapore 323
CN - Cina 261
DE - Germania 116
AR - Argentina 74
MA - Marocco 69
HK - Hong Kong 46
EC - Ecuador 38
ID - Indonesia 36
MX - Messico 30
FR - Francia 25
PK - Pakistan 19
BD - Bangladesh 18
ZA - Sudafrica 17
CO - Colombia 15
IN - India 14
IT - Italia 14
PY - Paraguay 14
RU - Federazione Russa 14
GB - Regno Unito 11
CL - Cile 7
CA - Canada 6
EG - Egitto 6
VE - Venezuela 6
AT - Austria 5
DO - Repubblica Dominicana 5
IQ - Iraq 5
UY - Uruguay 5
DZ - Algeria 4
FI - Finlandia 4
PE - Perù 4
HN - Honduras 3
NL - Olanda 3
NP - Nepal 3
SE - Svezia 3
AL - Albania 2
AZ - Azerbaigian 2
ES - Italia 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
PL - Polonia 2
RS - Serbia 2
SN - Senegal 2
TR - Turchia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
CR - Costa Rica 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
MU - Mauritius 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UA - Ucraina 1
Totale 2.903
Salva come PNG Salva come JPEG
Città #
Dallas 505
Singapore 151
Ho Chi Minh City 128
Frankfurt am Main 96
Ashburn 66
Hefei 65
Casablanca 63
The Dalles 58
Hanoi 53
Beijing 42
Hong Kong 42
San Jose 39
São Paulo 36
Mexico City 17
Guayaquil 16
Rio de Janeiro 16
Curitiba 15
Haiphong 15
Islamabad 15
New York 14
Da Nang 12
Thái Bình 11
Brasília 10
Quito 10
Bắc Giang 9
Johannesburg 9
Los Angeles 9
Munich 9
Porto Alegre 9
Asunción 8
Biên Hòa 8
Düsseldorf 8
Jakarta 8
Buenos Aires 7
Belo Horizonte 6
Campinas 6
Guarulhos 6
Hillsboro 6
Hải Dương 6
Ribeirão Preto 6
Cao Lanh 5
Fortaleza 5
Lauterbourg 5
Ninh Bình 5
Sorocaba 5
Sumaré 5
São José dos Campos 5
Thái Nguyên 5
Belford Roxo 4
Canoas 4
Caxias do Sul 4
Chennai 4
Chicago 4
Columbus 4
Corrientes 4
Cotia 4
Formosa 4
Huế 4
Maceió 4
Monterrey 4
Montes Claros 4
Montreal 4
New Delhi 4
Orem 4
Ourinhos 4
Paulista 4
Santo André 4
St Petersburg 4
São Gonçalo 4
Turku 4
Algiers 3
Atlanta 3
Bogotá 3
Brooklyn 3
Bắc Ninh 3
Can Tho 3
Cape Town 3
Contagem 3
Curvelo 3
Goiânia 3
Hortolândia 3
Juiz de Fora 3
Lima 3
Lomas de Zamora 3
Lấp Vò 3
Mauá 3
Medellín 3
Mogi das Cruzes 3
Montevideo 3
Novo Hamburgo 3
Phủ Lý 3
Quận Một 3
Recife 3
Santiago 3
Santos 3
Taboão da Serra 3
Yên Bái 3
Alvorada 2
Amman 2
Amsterdam 2
Totale 1.830
Salva come PNG Salva come JPEG
Nome #
Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liver 201
Procoagulant imbalance is associated with hepatic and vascular complications in patients with MASLD and diabetes. Key role of factor VIII 161
Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus 67
Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective 58
A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies 58
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 56
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 54
Clinical Characteristics and Predictors of Outcomes of Hospitalized Patients With Coronavirus Disease 2019 in a Multiethnic London National Health Service Trust: A Retrospective Cohort Study 54
A two-sample Mendelian randomization study to identity microbiome signatures in patients with Non-alcoholic fatty liver disease 54
Current and future pharmacological therapies for managing cirrhosis and its complications 54
A two-sample Mendelian randomization study to identity microbiome signatures in patients with Non-alcoholic fatty liver disease 53
Binge-eating disorder is associated with an unfavorable body mass composition in patients with non-alcoholic fatty liver disease 53
Automated quantitation of histological features could predict mortality in patients with severe alcoholic hepatitis 52
Analogs in the treatment of chronic hepatitis B: real life experience with tenofovir and entecavir 51
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 51
Binge Eating Disorder is associated with an unfavourable body mass composition in patients with Non-Alcoholic fatty liver disease 51
A serum metabolic fingerprint may predict advanced fibrosis due to NAFLD in a cohort of diabetic patients 49
Current and future pharmacological therapies for managing cirrhosis and its complications 48
Deep Learning in Liver Biopsies using Convolutional Neural Networks 48
NAFLD: Time to apply quantitation in liver biopsies as endpoints in clinical trials 47
Automated quantitation of steatosis, inflammation, ballooning and fibrosis using machine learning in routine histological images of liver biopsies of patients with NAFLD 46
Another arrow in the NASH quiver? 45
Quantification of Liver Fibrosis-A Comparative Study 45
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 45
Non-alcoholic fatty liver disease in women - Current knowledge and emerging concepts 44
Detection of senescence using machine learning algorithms based on nuclear features 43
A prospective cohort study for the prevalence and screening policy of NAFLD in patients with T2DM in primary care 42
Liver function tests in NAFLD: Changes in upper normal limits, does it really matter? 42
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 42
Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease - authors' reply 42
IN-HOSPITAL MORTALITY IS ASSOCIATED WITH INFLAMMATORY RESPONSE IN NAFLD PATIENTS ADMITTED FOR COVID-19 41
Training of Deep Convolutional Neural Networks to Identify Critical Liver Alterations in Histopathology Image Samples 41
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 40
Non-alcoholic fatty liver disease and cardiovascular risk: an update 40
Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study 40
Fibrosis severity scoring on Sirius red histology with multiple-instance deep learning 39
Liver function tests in NAFLD: Changes in upper normal limits, does it really matter? 39
Fat Droplets Identification in Liver Biopsies using Supervised Learning Techniques 39
Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter? 38
Evaluating the impact of non-selective beta-blocker use in decompensated cirrhosis based on setting of patient care 37
Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease - authors' reply 37
THE ROLE OF SUB-MUCOSAL COLLAGEN DEPOSITION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 37
IMPACT OF BMI AND ETHNICITY ON HISTOLOGY AS ASSESSED BY AUTOMATED QUANTITATION IN LIVER BIOPSIES OF PATIENTS WITH NAFLD 37
Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease: The importance of an elevated mean platelet volume 36
Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease 35
Automated Quantitation of Steatosis, Fibrosis and Ballooning Using Machine Learning in Routine Histological Images of Liver Biopsies of Patients with NAFLD 35
In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19 34
Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply 34
Ensemble Convolutional Neural Network Classification for Pancreatic Steatosis Assessment in Biopsy Images 34
Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume 33
Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply 33
SUB-MUCOSAL COLLAGEN DEPOSITION IS ASSOCIATED WITH INFLAMMATION MARKERS AND DISEASE ACTIVITY INDICES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: AN ONGOING STUDY 33
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 33
Letter: liver disease and COVID-19-not the perfect storm 33
The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease 32
Non-Alcoholic Fatty Liver Disease and Vascular Disease 32
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie SocietA Italiana di Medicina Interna) Study 32
High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease 31
Screening for NAFLD-Current Knowledge and Challenges 31
Non-alcoholic fatty liver disease and cardiovascular risk: an update 30
Gut Microbiota-A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic Review 30
Multi-tissue pro fi ling of oxylipins reveal a conserved up-regulation of epoxide:diol ratio that associates with white adipose tissue in fl ammation and liver steatosis in obesity 30
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 30
Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study 29
Transfer Learning versus Custom CNN Architectures in NAFLD Biopsy Images 27
Totale 2.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.765
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025282 0 0 0 0 0 0 0 0 160 34 76 12
2025/20262.686 73 345 682 900 155 42 125 113 77 174 0 0
Totale 2.968